TNGTransgeneTNG info
$1.15info0.00%24h
Global rank20411
Market cap$116.35M
Change 7d-
YTD Performance-24.89%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Transgene (TNG) Stock Overview

    Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase I clinical trial for the treatment of ovarian cancer, and head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of HPV-positive cancers; TG6002, an oncolytic virus that is in Phase I/IIa clinical trial for the treatment of gastrointestinal and colorectal cancers; and BT-001, an oncolytic virus, which is in Phase I/II clinical trial for the treatment of solid tumors. The company also develops TG1050, a therapeutic vaccine for the treatment of hepatitis B; TG6050 for the treatment of non-small cell lung cancer, and Pexa-Vec, an oncolytic virus for the treatment of solid tumors. It has strategic collaboration agreements with AstraZeneca, Merck KGaA, Pfizer, and NEC Corporation; licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva; and agreements with Merck & Co, Sanofi, BioInvent, and Randox. Transgene SA was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS.

    TNG Stock Information

    Symbol
    TNG
    Address
    400, boulevard Gonthier d’AndernachIllkirch-Graffenstaden, 67405France
    Founded
    -
    Trading hours
    -
    Website
    https://www.transgene.fr
    Country
    🇫🇷 France
    Phone Number
    33 3 88 27 91 00

    Transgene (TNG) Price Chart

    -
    Value:-

    Transgene Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.15
    N/A
    Market Cap
    $116.35M
    N/A
    Shares Outstanding
    100.85M
    N/A
    Employees
    143.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org